Span Divergent Ltd
₹ 31.9
5.00%
01 Dec
- close price
About
Incorporated in 1972, Span Divergent Ltd deals in different businesses through various subsidiaries.[1]
Key Points
- Market Cap ₹ 17.4 Cr.
- Current Price ₹ 31.9
- High / Low ₹ 45.3 / 19.0
- Stock P/E
- Book Value ₹ -5.57
- Dividend Yield 0.00 %
- ROCE -187 %
- ROE %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -0.91% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Loading peers table ...
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81.03 | 75.47 | 0.00 | 2.87 | 14.57 | 24.14 | 9.38 | 7.40 | 13.09 | 12.52 | 12.33 | 8.96 | 11.17 | |
| 77.14 | 74.28 | 5.23 | 8.37 | 25.16 | 31.34 | 15.16 | 9.64 | 12.67 | 11.42 | 10.94 | 9.61 | 12.99 | |
| Operating Profit | 3.89 | 1.19 | -5.23 | -5.50 | -10.59 | -7.20 | -5.78 | -2.24 | 0.42 | 1.10 | 1.39 | -0.65 | -1.82 |
| OPM % | 4.80% | 1.58% | -191.64% | -72.68% | -29.83% | -61.62% | -30.27% | 3.21% | 8.79% | 11.27% | -7.25% | -16.29% | |
| 0.55 | 53.94 | 9.98 | 4.04 | 2.57 | -0.76 | 1.96 | 0.82 | -7.54 | -3.45 | 1.77 | 1.25 | 1.94 | |
| Interest | 4.41 | 4.39 | 0.03 | 0.20 | 1.70 | 1.89 | 1.99 | 1.58 | 1.08 | 1.00 | 0.72 | 0.60 | 0.53 |
| Depreciation | 4.85 | 5.96 | 0.18 | 0.82 | 2.60 | 3.62 | 3.45 | 3.11 | 2.17 | 2.17 | 1.64 | 1.09 | 1.06 |
| Profit before tax | -4.82 | 44.78 | 4.54 | -2.48 | -12.32 | -13.47 | -9.26 | -6.11 | -10.37 | -5.52 | 0.80 | -1.09 | -1.47 |
| Tax % | 30.29% | 12.93% | 27.97% | 5.24% | 1.46% | 4.31% | -7.02% | 0.82% | -2.12% | -1.81% | 2.50% | 17.43% | |
| -6.28 | 38.99 | 3.28 | -2.61 | -12.50 | -14.05 | -8.61 | -6.16 | -10.15 | -5.42 | 0.79 | -1.28 | -1.59 | |
| EPS in Rs | -8.66 | 53.59 | 6.06 | -4.78 | -22.89 | -22.28 | -14.23 | -10.23 | -17.94 | -9.25 | 1.79 | -1.68 | -2.32 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -19% |
| 5 Years: | -1% |
| 3 Years: | -12% |
| TTM: | -11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 13% |
| 3 Years: | 4% |
| TTM: | -228% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | 17% |
| 3 Years: | 35% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.28 | 7.28 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 |
| Reserves | 15.35 | 54.41 | 44.71 | 43.11 | 30.61 | 19.87 | 12.12 | 6.56 | -3.24 | -8.30 | -7.35 | -8.27 | -8.50 |
| 37.52 | 0.34 | 0.19 | 13.12 | 23.18 | 22.30 | 19.19 | 17.99 | 13.19 | 11.15 | 9.11 | 8.36 | 7.34 | |
| 29.38 | 3.80 | 0.44 | 2.97 | 4.02 | 1.64 | 2.56 | 4.27 | 12.27 | 17.02 | 16.64 | 17.28 | 23.27 | |
| Total Liabilities | 89.53 | 65.83 | 50.80 | 64.66 | 63.27 | 49.27 | 39.33 | 34.28 | 27.68 | 25.33 | 23.86 | 22.83 | 27.57 |
| 41.26 | 2.20 | 2.15 | 8.15 | 25.91 | 22.47 | 20.19 | 17.72 | 15.36 | 13.12 | 10.75 | 9.64 | 9.87 | |
| CWIP | 1.75 | 0.09 | 0.06 | 10.95 | 0.00 | 0.06 | 0.13 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 45.81 | 35.55 | 27.87 | 25.50 | 16.36 | 10.07 | 9.43 | 4.03 | 3.95 | 4.69 | 6.30 | 5.43 |
| 46.52 | 17.73 | 13.04 | 17.69 | 11.86 | 10.38 | 8.94 | 7.11 | 8.29 | 8.26 | 8.42 | 6.89 | 12.27 | |
| Total Assets | 89.53 | 65.83 | 50.80 | 64.66 | 63.27 | 49.27 | 39.33 | 34.28 | 27.68 | 25.33 | 23.86 | 22.83 | 27.57 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.21 | 60.91 | -7.36 | -5.38 | -11.74 | -7.09 | -0.12 | -0.21 | 7.03 | 1.98 | 2.50 | 1.86 | |
| -4.80 | -12.13 | 13.39 | -5.55 | 0.81 | 10.05 | 5.89 | 1.99 | -2.05 | 0.53 | 0.12 | -1.05 | |
| -3.90 | -42.19 | -12.17 | 12.74 | 7.37 | -2.82 | -7.32 | -1.41 | -5.50 | -2.30 | -2.09 | -1.15 | |
| Net Cash Flow | -0.49 | 6.59 | -6.13 | 1.80 | -3.57 | 0.14 | -1.55 | 0.37 | -0.52 | 0.20 | 0.53 | -0.34 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 82.07 | 3.72 | 1.27 | 59.62 | 22.08 | 39.30 | 73.49 | 44.06 | 55.39 | 45.88 | 56.62 | |
| Inventory Days | 189.41 | 2.68 | 314.18 | 101.31 | 52.17 | 83.88 | 143.23 | 179.48 | 317.65 | 206.08 | 123.31 | |
| Days Payable | 116.44 | 1.17 | 78.54 | 39.95 | 12.44 | 79.35 | 298.01 | 213.76 | 526.78 | 480.26 | 426.66 | |
| Cash Conversion Cycle | 155.05 | 5.24 | 236.90 | 120.98 | 61.81 | 43.84 | -81.29 | 9.77 | -153.74 | -228.30 | -246.72 | |
| Working Capital Days | -68.69 | -7.01 | -705.84 | -228.22 | -185.98 | -310.52 | -400.02 | -428.58 | -599.98 | -608.63 | -930.83 | |
| ROCE % | -0.64% | -4.35% | -5.73% | -8.98% | -19.95% | -19.10% | -19.87% | -15.86% | -3.67% | -9.50% | 36.03% | -186.79% |
Documents
Announcements
-
Span Divergent Limited - Revised Outcome Of The Board Meeting - November 10, 2025
26 Nov - Approved Q2/H1 results; two directors resigned; Dharmesh Desai appointed; sold 99% subsidiary for INR99,000; exploring fundraising.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
11 Nov - Span Divergent Limited- Announcement under Regulation 30(LODR) News Paper Publication
-
Span Divergent Limited - Intimation Under Regulation 30
10 Nov - Span Divergent to reclassify Aranya Agri Biotech LLP assets as PPE and resume subsidiary operations (dated Nov 10, 2025).
-
Span Divergent Limited - Intimation For Sell / Transfer Of The Entire Investment Of The Company Held In Span Diagnostics LLP
10 Nov - Approved sale of 99% stake in Span Diagnostics LLP for INR 99,000 on Nov 10, 2025 to promoters.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
10 Nov - Dharmesh V. Desai appointed Additional Independent Director Nov 10, 2025–Nov 09, 2030 (subject to shareholder approval).
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
SDL operates across multiple business segments through dedicated subsidiaries in the Food, Agriculture, and Life Sciences verticals. It also provides management consulting and support services, offering financial, technical, and operational expertise to its group entities. The company actively oversees compliance, networking, and business development activities, while closely monitoring subsidiary performance and implementing strategic guidance and corrective measures as approved by the Board.